As of May 29
| -0.40 / -0.54%|
The 22 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 80.50, with a high estimate of 86.00 and a low estimate of 64.00. The median estimate represents a +9.15% increase from the last price of 73.75.
The current consensus among 26 polled investment analysts is to Buy stock in St. Jude Medical. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.